Paler, Porsincia .

HRN: 23-71-57  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/16/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/16/2023
09/23/2023
IV
1.5gram
Q6
CAP-MR
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: